SUVRETTA CAPITAL MANAGEMENT, LLC — 13F Holdings & Portfolio
CIK 1569064 · latest 13F-HR filed 2026-05-15
SUVRETTA CAPITAL MANAGEMENT, LLC manages $3.92B in 13F-reported U.S. long-equity assets across 89 reported positions as of its 2026-03-31 13F-HR filing. Its largest disclosed positions are ARQT (7.42%), MANE (6.72%), SPY (5.81%). Quarter over quarter (versus its 2025-12-31 filing) the fund opened 15 new positions, exited 17, added to 22, and trimmed 43.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
$3.92B
Long-equity book
89
Distinct positions
2026-03-31
Filed 2026-05-15
+15 / −17 / ↑22 / ↓43
vs 2025-12-31
| Name | Title / Status | Ownership | Type |
|---|
Top Adds (vs prior quarter)
- CAPRICOR THERAPEUTICS INC$64.6M +125.3%
- PALVELLA THERAPEUTICS INC NE$50.4M +53.9%
- APELLIS PHARMACEUTICALS INC$37.6M +36.1%
- MGM RESORTS INTERNATIONAL$36.0M +82.1%
- REPLIMUNE GROUP INC$31.9M +9120.1%
Top Trims
- MICROSOFT CORP-$75.4M -97.6%
- ARCUTIS BIOTHERAPEUTICS INC-$57.0M -16.4%
- DANAHER CORP DEL-$49.0M -87.7%
- AMAZON COM INC-$40.8M -43.6%
- TESLA INC-$39.1M -95.3%
New Positions
- VERADERMICS INC$263.3M
- VULCAN MATLS CO$49.4M
- CRINETICS PHARMACEUTICALS IN$37.9M
- US FOODS HLDG CORP$36.5M
- PERFORMANCE FOOD GROUP CO$33.1M
Exited Positions
- COCA COLA CO$96.7M
- SERVICENOW INC$59.7M
- SALESFORCE INC$53.0M
- ULTRAGENYX PHARMACEUTICAL IN$46.4M
- ORACLE CORP$44.1M
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 03969K108 | $290.4M | 7.42% | 12,327,000 | SH |
| 2 | VERADERMICS INC | MANE | 922967104 | $263.3M | 6.72% | 4,168,970 | SH |
| 3 | STATE STR SPDR S&P 500 ETF T Put | SPY | 78462F103 | $227.6M | 5.81% | 350,000 | SH |
| 4 | PALVELLA THERAPEUTICS INC NE | PVLA | 697947109 | $143.8M | 3.67% | 1,153,496 | SH |
| 5 | APELLIS PHARMACEUTICALS INC | APLS | 03753U106 | $141.5M | 3.62% | 3,518,471 | SH |
| 6 | LEGEND BIOTECH CORP | LEGN | 52490G102 | $137.1M | 3.50% | 7,581,029 | SH |
| 7 | BENITEC BIOPHARMA INC | BNTC | 08205P209 | $123.0M | 3.14% | 11,548,351 | SH |
| 8 | CAPRICOR THERAPEUTICS INC | CAPR | 14070B309 | $116.1M | 2.97% | 3,818,600 | SH |
| 9 | IMMATICS N.V | IMTX | N44445109 | $110.1M | 2.81% | 11,190,129 | SH |
| 10 | ARCUS BIOSCIENCES INC | RCUS | 03969F109 | $108.7M | 2.78% | 5,030,993 | SH |
| 11 | EYEPOINT INC | EYPT | 30233G209 | $106.9M | 2.73% | 8,296,375 | SH |
| 12 | ARRIVENT BIOPHARMA INC | AVBP | 04272N102 | $101.5M | 2.59% | 4,401,083 | SH |
| 13 | TAIWAN SEMICONDUCTOR MANUFAC | TSM | 874039100 | $100.9M | 2.58% | 298,707 | SH |
| 14 | NVIDIA CORPORATION | NVDA | 67066G104 | $100.2M | 2.56% | 574,656 | SH |
| 15 | META PLATFORMS INC | META | 30303M102 | $97.1M | 2.48% | 169,707 | SH |
| 16 | KALVISTA PHARMACEUTICALS INC | KALV | 483497103 | $96.0M | 2.45% | 4,768,712 | SH |
| 17 | GE AEROSPACE | GE | 369604301 | $88.0M | 2.25% | 310,262 | SH |
| 18 | BIOHAVEN LTD | BHVN | G1110E107 | $87.0M | 2.22% | 10,286,937 | SH |
| 19 | SYSCO CORP | SYY | 871829107 | $82.7M | 2.11% | 1,159,156 | SH |
| 20 | MGM RESORTS INTERNATIONAL | MGM | 552953101 | $79.9M | 2.04% | 2,158,800 | SH |
| 21 | COMPASS THERAPEUTICS INC | CMPX | 20454B104 | $75.7M | 1.93% | 14,307,379 | SH |
| 22 | HOME DEPOT INC | HD | 437076102 | $72.9M | 1.86% | 221,590 | SH |
| 23 | KURA ONCOLOGY INC | KURA | 50127T109 | $69.7M | 1.78% | 8,575,422 | SH |
| 24 | MONTE ROSA THERAPEUTICS INC | GLUE | 61225M102 | $69.5M | 1.78% | 4,226,809 | SH |
| 25 | BANK AMERICA CORP | BAC | 060505104 | $63.1M | 1.61% | 1,295,245 | SH |
| 26 | ERASCA INC | ERAS | 29479A108 | $55.6M | 1.42% | 3,434,967 | SH |
| 27 | CAPITAL ONE FINL CORP | COF | 14040H105 | $55.2M | 1.41% | 302,400 | SH |
| 28 | ZURA BIO LTD | ZURA | G9TY5A101 | $53.9M | 1.38% | 9,067,001 | SH |
| 29 | AMAZON COM INC | AMZN | 023135106 | $52.9M | 1.35% | 254,009 | SH |
| 30 | ADVANCED MICRO DEVICES INC | AMD | 007903107 | $52.3M | 1.34% | 257,240 | SH |
| 31 | FULCRUM THERAPEUTICS INC | FULC | 359616109 | $50.3M | 1.29% | 6,561,111 | SH |
| 32 | VULCAN MATLS CO | VMC | 929160109 | $49.4M | 1.26% | 181,594 | SH |
| 33 | FERGUSON ENTERPRISES INC | FERG | 31488V107 | $49.4M | 1.26% | 211,900 | SH |
| 34 | APOLLO GLOBAL MGMT INC | APO | 03769M106 | $43.2M | 1.10% | 387,700 | SH |
| 35 | MINERALYS THERAPEUTICS INC | MLYS | 603170101 | $41.7M | 1.06% | 1,538,662 | SH |
| 36 | CRINETICS PHARMACEUTICALS IN | CRNX | 22663K107 | $37.9M | 0.97% | 1,043,879 | SH |
| 37 | CONTINEUM THERAPEUTICS INC | CTNM | 21217B100 | $37.1M | 0.95% | 2,841,334 | SH |
| 38 | US FOODS HLDG CORP | USFD | 912008109 | $36.5M | 0.93% | 395,970 | SH |
| 39 | PERFORMANCE FOOD GROUP CO | PFGC | 71377A103 | $33.1M | 0.85% | 386,885 | SH |
| 40 | REPLIMUNE GROUP INC | REPL | 76029N106 | $32.3M | 0.82% | 4,221,836 | SH |
| 41 | ADVISORSHARES TR | MSOS | 00768Y453 | $32.1M | 0.82% | 9,046,200 | SH |
| 42 | AURA BIOSCIENCES INC | AURA | 05153U107 | $29.3M | 0.75% | 4,372,884 | SH |
| 43 | UNITEDHEALTH GROUP INC | UNH | 91324P102 | $27.2M | 0.70% | 100,630 | SH |
| 44 | PROKIDNEY CORP | PROK | 74291D104 | $22.1M | 0.56% | 12,341,266 | SH |
| 45 | LIFE TIME GROUP HOLDINGS INC | LTH | 53190C102 | $13.7M | 0.35% | 510,349 | SH |
| 46 | WHITEHAWK THERAPEUTICS INC | WHWK | 00032Q104 | $12.8M | 0.33% | 3,700,000 | SH |
| 47 | ABEONA THERAPEUTICS INC | ABEO | 00289Y206 | $12.0M | 0.31% | 2,676,000 | SH |
| 48 | WINGSTOP INC | WING | 974155103 | $9.2M | 0.24% | 59,500 | SH |
| 49 | MOLECULAR PARTNERS AG | MOLN | 60853G106 | $8.8M | 0.23% | 2,221,494 | SH |
| 50 | BOSTON SCIENTIFIC CORP | BSX | 101137107 | $7.8M | 0.20% | 123,941 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-03-31 | 2026-05-15 | $3.92B | 89 | 0001172661-26-002340 |
| 2025-12-31 | 2026-02-17 | $4.88B | 93 | 0001172661-26-001088 |
| 2025-09-30 | 2025-11-14 | $3.91B | 93 | 0001172661-25-004838 |